Current studies in tumor-associated B cells, such as the regulatory B cells, mainly focused on the secretion of IL-10 and TGF-β, which might contribute to the function of T cells and therapy effect of T cell-mediated immune response [36]. This evidence concerns the gene TGFB1 and neoplasm.